Loading viewer...
investor_presentation
Format: PDF investor_presentation
a.s.r. presented its inaugural euro-denominated perpetual Restricted Tier 1 Contingent Convertible Notes offering in October 2017. The presentation outlines the issuer's capital management strategy, strong solvency position with a 194% Solvency II SCR ratio, and investment thesis for Dutch insurance operations. The notes feature perpetual maturity with a 10-year non-call period and equity conversion upon specified trigger events.
Virpax Pharmaceuticals VRPX Investor Presentation August 2023
investor_presentationinvestor_presentation
29 Pages
Virpax Pharmaceuticals, Inc.
investor_presentation
Cohu
Allscripts Healthcare Solutions 2020 Investor Presentation
investor_presentationinvestor_presentation
20 Pages
Allscripts Healthcare Solutions
investor_presentation
Atomera